NanoString's miRGE Assay now available for use in nCounter Analysis System

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the availability of the nCounter® miRGE Assay for use on its nCounter Analysis System. The nCounter miRGE ("merge") Assay enables researchers to investigate expression levels of both micro RNAs (miRNAs) and the messenger RNAs (mRNAs) they potentially regulate in a single reaction, without the need for amplification.

The miRGE Assay provides the capacity to perform multiplexed profiling of 5-30 miRNAs and 100-200 mRNAs simultaneously, with specificity and sensitivity comparable to qPCR. Like all nCounter assays, the kit is compatible with multiple sample types, including FFPE samples. The assay is available for human, mouse and rat samples.

"The miRGE Assay is a unique, digital assay that will enable researchers to investigate the interactions between miRNAs and their downstream mRNA targets, all in a single tube," said Barney Saunders, Chief Commercial Officer for NanoString Technologies. "miRGE delivers highly reproducible results, even for challenging samples such as FFPE tissue, making it ideal for today's translational research studies."

The nCounter Analysis System is a fully automated digital detection and counting system with a very simple workflow. The assays contain all of the reagents and consumables required to conduct an experiment. Minimal sample input requirements and compatibility with a variety of sample types, extends the utility of the platform. In addition to miRNA assays, NanoString provides assays for copy number variation and gene expression analysis. The nCounter Analysis System is currently available for Research Use Only.

Source: NanoString Technologies, Inc.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Nanostring. (2011, September 22). NanoString's miRGE Assay now available for use in nCounter Analysis System. News-Medical. Retrieved on August 08, 2022 from https://www.news-medical.net/news/20110922/NanoStrings-miRGE-Assay-now-available-for-use-in-nCounter-Analysis-System.aspx.

  • MLA

    Nanostring. "NanoString's miRGE Assay now available for use in nCounter Analysis System". News-Medical. 08 August 2022. <https://www.news-medical.net/news/20110922/NanoStrings-miRGE-Assay-now-available-for-use-in-nCounter-Analysis-System.aspx>.

  • Chicago

    Nanostring. "NanoString's miRGE Assay now available for use in nCounter Analysis System". News-Medical. https://www.news-medical.net/news/20110922/NanoStrings-miRGE-Assay-now-available-for-use-in-nCounter-Analysis-System.aspx. (accessed August 08, 2022).

  • Harvard

    Nanostring. 2011. NanoString's miRGE Assay now available for use in nCounter Analysis System. News-Medical, viewed 08 August 2022, https://www.news-medical.net/news/20110922/NanoStrings-miRGE-Assay-now-available-for-use-in-nCounter-Analysis-System.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
NanoString Technologies launches “Dear Cancer Researchers” campaign